BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2017

Jun 21, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2017-06-16

Reporting Person: FUCHS HENRY J (President, Worldwide R&D)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-06-16	Common Stock	M	5000	$26.49	Acquired	141422	Direct
2017-06-16	Common Stock	M	9397	$37.46	Acquired	150819	Direct
2017-06-16	Common Stock	S	5000	$90	Disposed	145819	Direct
2017-06-16	Common Stock	S	9397	$90	Disposed	136422	Direct
2017-06-19	Common Stock	M	603	$37.46	Acquired	137025	Direct
2017-06-19	Common Stock	S	603	$90	Disposed	136422	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-06-16	Stock Option (right to buy) Common Stock	$26.49	M	5000	Disposed	2021-05-11	Common Stock (5000)	Direct
2017-06-16	Stock Option (right to buy) Common Stock	$37.46	M	9397	Disposed	2022-05-07	Common Stock (9397)	Direct
2017-06-19	Stock Option (right to buy) Common Stock	$37.46	M	603	Disposed	2022-05-07	Common Stock (603)	Direct

Footnotes

F1: Trade made pursuant to a 10b5-1 plan executed on May 9, 2017.

F2: All shares sold at the same price.

F3: Reflects the number of options outstanding after the transactions from this specific stock option grant.